Supplemental material
Journal of Biomolecular Structure and Dynamics
Volume 40, 2022 - Issue 12
Research Articles
Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study
Khadijeh Ahmadia Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; 
https://orcid.org/0000-0003-4669-0708View further author information
https://orcid.org/0000-0003-4669-0708View further author information, , Mosayeb Rostamiand Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; https://orcid.org/0000-0002-1071-7019View further author information
https://orcid.org/0000-0002-1071-7019View further author information, & Hamid Madanchif Department of Biotechnology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran; ;g Drug Design and Bioinformatics Unit, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, IranCorrespondence[email protected]
https://orcid.org/0000-0002-6527-7321View further author information
https://orcid.org/0000-0002-6527-7321View further author information